These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5068187)

  • 1. Serum creatinine and drug half-lives in renal failure.
    Perrier D; Gibaldi M
    JAMA; 1972 Aug; 221(8):918. PubMed ID: 5068187
    [No Abstract]   [Full Text] [Related]  

  • 2. Individualization of drug dosage in patients with renal disease.
    Dettli L
    Med Clin North Am; 1974 Sep; 58(5):977-85. PubMed ID: 4425338
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of age and lean body mass on the relation of creatinine clearance and drug half-life.
    Hallynck T; Pijck J; Soep H
    Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):330-2. PubMed ID: 7181594
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum creatinine and drug half-lives.
    Kampmann J; Hansen JM; Siersbaek-Nielsen K; Kristensen M
    JAMA; 1973 Jan; 223(2):193. PubMed ID: 4739466
    [No Abstract]   [Full Text] [Related]  

  • 5. Diseases of the urinary system. Prescribing for patients with renal failure.
    Sharpstone P
    Br Med J; 1977 Jul; 2(6078):36-7. PubMed ID: 871747
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Drug elimination and renal function.
    Kristensen M; Molholm HJ; Kampmann J; Lumholtz B; Siersbaek-Nielsen K
    J Clin Pharmacol; 1974; 14(5-6):307-8. PubMed ID: 4829522
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlation of serum creatinine concentration and amikacin half-life.
    Levy J; Klastensky J
    J Clin Pharmacol; 1975 Oct; 15(10):705-7. PubMed ID: 1102570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editorial: Drug metabolism in disease.
    Lancet; 1974 Apr; 1(7861):790-1. PubMed ID: 4132718
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug dosage in patients with renal disease.
    Dettli LC
    Clin Pharmacol Ther; 1974 Jul; 16(1):274-80. PubMed ID: 4843318
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of renal disease upon drug disposition.
    Reidenberg MM; Drayer DE
    Drug Metab Rev; 1978; 8(2):293-302. PubMed ID: 363386
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple dose kinetics and drug dosage in patients with kidney disease.
    Dettli L; Spring P; Ryter S
    Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():211-24. PubMed ID: 5316403
    [No Abstract]   [Full Text] [Related]  

  • 12. Dose regimen of kanamycin and gentamicin.
    Lumholtz B; Kampmann TJ; Siersbaek-Nielsen K; Hansen JM
    Acta Med Scand; 1974 Dec; 196(6):521-4. PubMed ID: 4456985
    [No Abstract]   [Full Text] [Related]  

  • 13. Calculation of drug dosage regimens in patients with renal disease: a new nomographic method.
    Spring P
    Int J Clin Pharmacol Biopharm; 1975 Jan; 11(1):76-80. PubMed ID: 1150365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of drug elimination in renal failure.
    Perrier D; Gibaldi M
    J Clin Pharmacol; 1973; 13(11):458-62. PubMed ID: 4490668
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antibiotic therapy in disturbed kidney function].
    Hitzenberger G
    Dtsch Med Wochenschr; 1971 Nov; 96(46):1805-6. PubMed ID: 5115872
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gentamicin and kidney diseases].
    Jacobsen S
    Tidsskr Nor Laegeforen; 1973 Jan; 93(1):36. PubMed ID: 4691224
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhanced drug metabolism and renal dysfunction.
    Németh I; Szeleczki T
    Br J Clin Pharmacol; 1981 Jan; 11(1):92-3. PubMed ID: 7213515
    [No Abstract]   [Full Text] [Related]  

  • 18. Significance of apparent half-lives of a metabolite with a higher elimination rate than its parent drug.
    Vree TB; Hekster CA; van der Kleijn E
    Drug Intell Clin Pharm; 1982 Feb; 16(2):126-31. PubMed ID: 7075463
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of host factors on drug response. VII. Renal diseases.
    Vesell ES
    Ration Drug Ther; 1981 Nov; 15(11):1-9. PubMed ID: 7345476
    [No Abstract]   [Full Text] [Related]  

  • 20. Kanamycin dosage in renal failure.
    Healy JK; Drum PJ; Elliott AJ
    Aust N Z J Med; 1973 Oct; 3(5):474-9. PubMed ID: 4521430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.